YTEN - Yield10 Bioscience Inc
Previous close
1.28
0 0%
Share volume: 115,032
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.28
0.00
0.00%
View ratios
| Fiscal Date | 2022-03-31 | 2022-06-30 | 2022-09-30 | 2022-12-31 | 2023-03-31 | |
|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | |
| Report Date | 2022-05-11 | 2022-08-10 | 2022-11-14 | 2023-03-14 | 2023-05-12 | |
| Assets | ||||||
| Total Assets | 17.104 M | 14.273 M | 11.272 M | 8.085 M | 5.334 M | |
| Current Assets | 13.375 M | 10.704 M | 7.895 M | 5.018 M | 2.443 M | |
| Inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other Current Assets | 451.000 K | 483.000 K | 414.000 K | 641.000 K | 634.000 K | |
| Short Term Investments | 451.000 K | 483.000 K | 414.000 K | 641.000 K | 634.000 K | |
| Total Receivables | 182.000 K | 63.000 K | 76.000 K | 30.000 K | 0.000 | |
| Current Cash | 12.742 M | 10.158 M | 7.405 M | 4.347 M | 1.809 M | |
| Total Non-current Assets | 3.729 M | 3.569 M | 3.377 M | 3.067 M | 2.891 M | |
| Property Plant Equipment | 945.000 K | 895.000 K | 840.000 K | 775.000 K | 715.000 K | |
| Other Assets | 261.000 K | 248.000 K | 210.000 K | 67.000 K | 55.000 K | |
| Intangible Assets | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Goodwill | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Liabilities and shareholders’ equity | ||||||
| Total Liabilities and shareholders’ equity | 17.104 M | 14.273 M | 11.272 M | 8.085 M | 5.334 M | |
| Total liabilities | 3.893 M | 4.002 M | 4.052 M | 3.685 M | 4.191 M | |
| Total current liabilities | 1.376 M | 1.627 M | 1.826 M | 1.610 M | 2.270 M | |
| Accounts Payable | 24.000 K | 24.000 K | 104.000 K | 109.000 K | 495.000 K | |
| Other liabilities | 5.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Current long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Long term debt | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Other liabilities | 5.000 K | 0.000 | 0.000 | 0.000 | 0.000 | |
| Minority interest | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Total Shareholder equity | 13.211 M | 10.271 M | 7.220 M | 4.400 M | 1.143 M | |
| Common stock | 4.889 M | 4.900 M | 4.925 M | 4.944 M | 5.000 M | |
| Retained earnings | -389.462 M | -392.905 M | -396.394 M | -399.697 M | -403.479 M |